Denali Therapeutics Inc. DNLI recently outlined its roadmap for 2026 across its portfolio of investigational therapies for neurodegenerative diseases, lysosomal storage disorders and other serious ...

Turns out Black got a bit too big for his britches requesting a rewrite, which ultimately got his Pixar offer revoked. Reading time 2 minutes No one would argue that Jack Black is an actor so ...

On any given day, Ajay Kirmeier might be behind a camera at a high school hockey game or helping manage traffic at a community event. At 19, the Mound native balances college, serving as a reserve ...

Preparing for FDA approval and commercial launch of tividenofusp alfa, Denali’s TransportVehicle™ (TV)-enabled investigational therapy for Hunter syndrome Expecting multiple clinical data readouts ...

Background: Cardiovascular Disease (CVD) represents a significant global public health challenge. Metabolic Syndrome (MetS) notably elevates the risk of CVD, with MetS patients facing approximately ...

When Maria Curtis was born on Jan. 29, 1963, at Naperville’s Edward Hospital, there were two reactions to her birth. There was the reaction from her mother, Gertrude Curtis, who saw a little girl and ...

Mucopolysaccharidosis II is currently treated with an enzyme replacement therapy that does not cross the blood-brain barrier and thus does not address the condition's neurologic consequences. This ...

AFTER GETTING VACCINATED. PERRY RUSSOM, ABC NEWS, WASHINGTON. NEW HAMPSHIRE RANKS 10TH IN THE COUNTRY IN LIFE EXPECTANCY. A NEW REPORT FROM THE CDC SHOWS THE AVERAGE LIFE EXPECTANCY IN THE STATE IS ...

Tividenofusp alfa treatment showed reduction and normalization in key disease biomarkers, stabilization or improvement in clinical endpoints including adaptive behavior, cognition and hearing, and ...

All McKay wants this holiday season is for new therapies for those with Hunter syndrome to be approved. "We really want the FDA to understand the urgency that putting a delay 'just three months,' for ...